Fusobacterium nucleatum promotes chemoresistance to 5-fluorouracil by upregulation of BIRC3 expression in colorectal cancer
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Fusobacterium nucleatum promotes chemoresistance to 5-fluorouracil by upregulation of BIRC3 expression in colorectal cancer
Authors
Keywords
<em class="EmphasisTypeItalic ">Fusobacterium nucleatum</em>, BIRC3, 5-fluorouracil, Chemoresistance, Colorectal cancer
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 38, Issue 1, Pages -
Publisher
Springer Nature
Online
2019-01-10
DOI
10.1186/s13046-018-0985-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Stress-inducible Protein-1 promotes metastasis of gastric cancer via Wnt/β-catenin signaling pathway
- (2018) Linlin Huang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- The gut microbiota influences anticancer immunosurveillance and general health
- (2018) Bertrand Routy et al. Nature Reviews Clinical Oncology
- Association between Fusobacterium nucleatum and colorectal cancer: Progress and future directions
- (2018) Sheng Zhang et al. Journal of Cancer
- Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor−κB, and Up-regulating Expression of MicroRNA-21
- (2017) Yongzhi Yang et al. GASTROENTEROLOGY
- Analysis ofFusobacteriumpersistence and antibiotic response in colorectal cancer
- (2017) Susan Bullman et al. SCIENCE
- Cancer statistics in China, 2015
- (2016) Wanqing Chen et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Microbiome and Anticancer Immunosurveillance
- (2016) Laurence Zitvogel et al. CELL
- Endothelial Cell Response to Fusobacterium nucleatum
- (2016) Reila Tainá Mendes et al. INFECTION AND IMMUNITY
- Microbiota dysbiosis: a new piece in the understanding of the carcinogenesis puzzle
- (2016) Valeria García-Castillo et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Promises and Challenges of Smac Mimetics as Cancer Therapeutics
- (2015) S. Fulda CLINICAL CANCER RESEARCH
- Fusobacterium nucleatumin colorectal carcinoma tissue and patient prognosis
- (2015) Kosuke Mima et al. GUT
- Binding of the Fap2 Protein of Fusobacterium nucleatum to Human Inhibitory Receptor TIGIT Protects Tumors from Immune Cell Attack
- (2015) Chamutal Gur et al. IMMUNITY
- Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy
- (2015) A. Sivan et al. SCIENCE
- Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
- (2015) M. Vetizou et al. SCIENCE
- Fusobacterium in Colonic Flora and Molecular Features of Colorectal Carcinoma
- (2014) T. Tahara et al. CANCER RESEARCH
- Gastrointestinal Malignancy and the Microbiome
- (2014) Maria T. Abreu et al. GASTROENTEROLOGY
- The multiple facets of drug resistance: one history, different approaches
- (2014) Evandro Niero et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- The gut microbiota, bacterial metabolites and colorectal cancer
- (2014) Petra Louis et al. NATURE REVIEWS MICROBIOLOGY
- Fusobacterium nucleatum Promotes Colorectal Carcinogenesis by Modulating E-Cadherin/β-Catenin Signaling via its FadA Adhesin
- (2013) Mara Roxana Rubinstein et al. Cell Host & Microbe
- Colorectal cancer
- (2013) Hermann Brenner et al. LANCET
- Dysbiosis Signature of Fecal Microbiota in Colorectal Cancer Patients
- (2013) Na Wu et al. MICROBIAL ECOLOGY
- Overexpression of YAP and TAZ Is an Independent Predictor of Prognosis in Colorectal Cancer and Related to the Proliferation and Metastasis of Colon Cancer Cells
- (2013) Lijuan Wang et al. PLoS One
- Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment
- (2013) N. Iida et al. SCIENCE
- NIRF is frequently upregulated in colorectal cancer and its oncogenicity can be suppressed by let-7a microRNA
- (2011) Feng Wang et al. CANCER LETTERS
- Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma
- (2011) M. Castellarin et al. GENOME RESEARCH
- Inhibitor of apoptosis protein family as diagnostic markers and therapeutic targets of colorectal cancer
- (2011) Koh Miura et al. SURGERY TODAY
- Survivin and IAP proteins in cell-death mechanisms
- (2010) Dario C. Altieri BIOCHEMICAL JOURNAL
- Challenges of drug resistance in the management of pancreatic cancer
- (2010) Rizwan Sheikh et al. Expert Review of Anticancer Therapy
- Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer
- (2010) Daniel J. Sargent et al. JOURNAL OF CLINICAL ONCOLOGY
- Multiple Drug Resistance Mechanisms in Cancer
- (2010) Bruce C. Baguley MOLECULAR BIOTECHNOLOGY
- Down-regulation of cIAP2 enhances 5-FU sensitivity through the apoptotic pathway in human colon cancer cells
- (2009) Hideaki Karasawa et al. CANCER SCIENCE
- cIAP2 as a therapeutic target in colorectal cancer and other malignancies
- (2009) Koh Miura et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- IAP-targeted therapies for cancer
- (2008) E C LaCasse et al. ONCOGENE
- Ghrelin prevents doxorubicin-induced cardiotoxicity through TNF-alpha/NF-κB pathways and mitochondrial protective mechanisms
- (2008) Zhiwei Xu et al. TOXICOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now